Narcan vending machines help communities save fentanyl users' lives
National media features UC research and partnership with Caracole
United Press International, Yahoo News and MSN highlighted research from the University of Cincinnati's Daniel Arendt in a story on the rise of harm reduction vending machines across the country.
Cincinnati nonprofit Caracole, in partnership with the University of Cincinnati, has operated a machine outside of its headquarters since 2021.
The machine provides an anonymous way for anyone in the community to access free supplies including naloxone, the drug that can be used to reverse an overdose, safe injection kits, safe smoking kits and more.
Arendt, PharmD, has been tracking the machine's use since its inception, with the latest reports showing naloxone accessed from the machine led to the reversal of more than 3,000 overdoses.
"We also ask users about their experiences using the materials," Arendt, assistant professor in UC’s James L. Winkle College of Pharmacy and co-chair of the pain stewardship committee for UC Health, told UPI. "For instance, many of our users take fentanyl test strips, and about 50% of the time, when fentanyl is detected, users either lower their dose or discard the substance."
Arendt's research has also found the machines' success largely depends on location, hours of operation, accessibility and the variety of products available.
"We have also seen usage grow overtime as people in the community begin to trust the machine more and recognize that it isn't a trap set up by police or something," he added. "That increased relationship with the community itself and building that trust is instrumental in having a successful program."
Read the United Press International story, which was also published on Yahoo News and MSN.
Read more about the Caracole-UC partnership and initial research data published in 2022.
Featured photo at top of naloxone doses. Photo/Pharmacy Images/Unsplash.
Related Stories
Can new research improve the safety of AI therapy for teens?
December 5, 2025
The University of Cincinnati's Stephen Rush joined WVXU's Cincinnati Edition for a discussion on the growing trend of young people turning to artificial intelligence for mental health support and therapy.
Student-designed AI platform aims to match patients to specific cancer support groups
December 5, 2025
The University of Cincinnati is launching a clinical trial testing a student-designed, machine-learning powered platform to match patients with cancer to support groups specifically tailored to their needs and concerns.
What would expanded access to GLP-1s mean for the obesity rate?
December 4, 2025
The World Health Organization recently issued its first guidance on GLP-1 medications for adults with obesity — recommending long-term, continuous use when clinically appropriate. Malti Vij, MD, University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine, appeared on Cincinnati Edition on 91.7 WVXU News to discuss GLP-1s and what expanded insurance coverage of the medications might mean for Americans.